Impact, in this context, is not a feel-good narrative; it’s a measurable one, even if more qualitatively than quantitatively in some cases. For me, it’s about which healthspan outcome is being targeted, for whom and why? How will progress be measured with replicable methods? What would count as failure? What tradeoffs are acceptable, and which ones are not? When founders and investors are aligned on these questions, capital becomes a tool for building evidence rather than amplifying narrative.
<!-- WebClient（模拟第三方调用，非阻塞，配合虚拟线程更香） --。同城约会对此有专业解读
Natalie ShermanBusiness reporter，更多细节参见91视频
Go to worldnews
美以聯手攻擊伊朗致哈梅內伊喪生以及伊朗的報復性打擊——我們目前知道什麼？